3381 - 3390 of 6509 Results
Title
Year
-
OPENTitle: Stability Evaluation of Brain Changes in Parkinson's Disease Based on Machine LearningJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 735991End Page: 735991Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2021.735991Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncom.2021.735991/pdfCitation Count: 14
-
OPENTitle: Mitochondrial Defects in Fibroblasts of Pathogenic MAPT PatientsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page: 765408End Page: 765408Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2021.765408Best OA location URL: https://doi.org/10.3389/fcell.2021.765408Citation Count: 7
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial2021OPENTitle: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2408End Page: 2412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28702Best OA location URL: https://doi.org/10.1002/mds.28702Citation Count: 18
-
OPENTitle: Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 729635End Page: 729635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.729635Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.729635/pdfCitation Count: 22
-
OPENTitle: Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 109333End Page: 109333Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.109333Best OA location URL: http://www.cell.com/article/S2211124721007099/pdfCitation Count: 47
-
OPENTitle: Herpesvirus Infections and Risk of Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 20Issue #: 2-3Start Page: 97End Page: 103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000512874Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8552529Citation Count: 28
-
OPENTitle: Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 10Start Page: e2344End Page: e2344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2344Best OA location URL: https://doi.org/10.1002/brb3.2344Citation Count: 13
-
OPENTitle: Mental health in people with Parkinson’s disease during the COVID-19 pandemic: potential for targeted interventions?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 95End Page: 95Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00238-yBest OA location URL: https://www.nature.com/articles/s41531-021-00238-y.pdfCitation Count: 20
-
OPENTitle: Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2837End Page: 2851Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab170Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2837/40880314/awab170.pdfCitation Count: 29
-
OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 26